Does Haloperidol Cause Urinary Incontinence?
Haloperidol can cause urinary retention more commonly than urinary incontinence, though incontinence has been reported as a rare adverse effect. The FDA drug label lists urinary retention as an autonomic reaction, while a large pharmacovigilance study found haloperidol was associated with urological adverse effects, primarily retention rather than incontinence 1, 2.
Understanding the Urological Effects
Primary Effect: Urinary Retention
Haloperidol's anticholinergic properties predominantly cause urinary retention rather than incontinence 1. The FDA label explicitly lists "urinary retention" under autonomic reactions, which is the more common urological side effect you should anticipate and monitor for.
Incontinence as a Rare Effect
While less common, urinary incontinence has been documented:
- A large German pharmacovigilance study of 462,661 psychiatric inpatients found haloperidol was among the antipsychotics with the highest rate of urological adverse drug reactions, though the overall incidence was low (0.037%) 2
- Among 171 cases of severe urological adverse effects, urinary retention (129 cases, 0.028%) vastly outnumbered incontinence (23 cases, 0.005%) 2
- The mechanism for incontinence when it occurs may relate to sedation, cognitive effects, or paradoxical bladder dysfunction
Clinical Context and Risk Factors
Patients at higher risk for urological complications include:
- Older adults, particularly those with pre-existing bladder dysfunction
- Patients with diabetes (who have baseline increased incontinence risk from neurogenic bladder) 3, 4, 3
- Those on multiple medications with anticholinergic effects
- Patients with cognitive impairment or delirium 5
The 2018 ESMO delirium guidelines note haloperidol may cause extrapyramidal side effects but do not specifically highlight incontinence as a primary concern, focusing instead on QTc prolongation and movement disorders 5.
What to Monitor
When prescribing haloperidol, assess for:
- Urinary retention symptoms: difficulty initiating urination, incomplete emptying, decreased urinary frequency
- Incontinence symptoms: involuntary urine loss (though less common)
- Post-void residual volumes in high-risk patients
- Concurrent medications that may compound anticholinergic burden
Management Approach
If urological symptoms develop:
- First, rule out urinary retention (the more likely culprit) through physical examination and post-void residual measurement
- Evaluate for other contributing factors: concurrent medications, fecal impaction, urinary tract infection, or underlying neurogenic bladder 3
- Consider dose reduction if symptoms are clearly temporally related to haloperidol initiation or dose escalation
- If retention is the issue, avoid adding anticholinergic antiparkinson agents which would worsen the problem 1
Important Caveats
The evidence specifically linking haloperidol to incontinence is limited. Most urological adverse effects are retention-related due to anticholinergic properties. When incontinence occurs with antipsychotics, it's more commonly reported with clozapine than haloperidol 2. The 2025 geriatric emergency guidelines examining haloperidol safety in agitation did not identify urinary incontinence as a significant adverse event in their systematic review 6.
Bottom line: While possible, urinary incontinence is not a characteristic or common side effect of haloperidol—urinary retention is the primary urological concern. If incontinence develops in a patient on haloperidol, investigate other causes thoroughly before attributing it solely to the medication.